Literature DB >> 23620276

Codon optimisation to improve expression of a Mycobacterium avium ssp. paratuberculosis-specific membrane-associated antigen by Lactobacillus salivarius.

Christopher Johnston1, Pierre E Douarre, Tewfik Soulimane, Daniel Pletzer, Helge Weingart, John MacSharry, Aidan Coffey, Roy D Sleator, Jim O'Mahony.   

Abstract

Subunit and DNA-based vaccines against Mycobacterium avium ssp. paratuberculosis (MAP) attempt to overcome inherent issues associated with whole-cell formulations. However, these vaccines can be hampered by poor expression of recombinant antigens from a number of disparate hosts. The high G+C content of MAP invariably leads to a codon bias throughout gene expression. To investigate if the codon bias affects recombinant MAP antigen expression, the open reading frame of a MAP-specific antigen MptD (MAP3733c) was codon optimised for expression against a Lactobacillus salivarius host. Of the total 209 codons which constitute MAP3733c, 172 were modified resulting in a reduced G+C content from 61% for the native gene to 32.7% for the modified form. Both genes were placed under the transcriptional control of the PnisA promoter; allowing controlled heterologous expression in L. salivarius. Expression was monitored using fluorescence microscopy and microplate fluorometry via GFP tags translationally fused to the C-termini of the two MptD genes. A > 37-fold increase in expression was observed for the codon-optimised MAP3733synth variant over the native gene. Due to the low cost and improved expression achieved, codon optimisation significantly improves the potential of L. salivarius as an oral vaccine stratagem against Johne's disease.
© 2013 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23620276     DOI: 10.1111/2049-632X.12040

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  8 in total

Review 1.  Designer probiotics: Development and applications in gastrointestinal health.

Authors:  Roy D Sleator
Journal:  World J Gastrointest Pathophysiol       Date:  2015-08-15

Review 2.  Under the microscope: From pathogens to probiotics and back.

Authors:  Roy D Sleator
Journal:  Bioengineered       Date:  2015       Impact factor: 3.269

3.  The genetic code. Rewritten, revised, repurposed.

Authors:  Roy D Sleator
Journal:  Artif DNA PNA XNA       Date:  2014

Review 4.  Metagenomics and novel gene discovery: promise and potential for novel therapeutics.

Authors:  Eamonn P Culligan; Roy D Sleator; Julian R Marchesi; Colin Hill
Journal:  Virulence       Date:  2013-04-01       Impact factor: 5.882

5.  Enhanced expression of codon optimized Mycobacterium avium subsp. paratuberculosis antigens in Lactobacillus salivarius.

Authors:  Christopher D Johnston; John P Bannantine; Rodney Govender; Lorraine Endersen; Daniel Pletzer; Helge Weingart; Aidan Coffey; Jim O'Mahony; Roy D Sleator
Journal:  Front Cell Infect Microbiol       Date:  2014-09-04       Impact factor: 5.293

Review 6.  Pathogenesis, Molecular Genetics, and Genomics of Mycobacterium avium subsp. paratuberculosis, the Etiologic Agent of Johne's Disease.

Authors:  Govardhan Rathnaiah; Denise K Zinniel; John P Bannantine; Judith R Stabel; Yrjö T Gröhn; Michael T Collins; Raúl G Barletta
Journal:  Front Vet Sci       Date:  2017-11-06

7.  Development of bicistronic expression system for the enhanced and reliable production of recombinant proteins in Leuconostoc citreum.

Authors:  Seung Hoon Jang; Ji Won Cha; Nam Soo Han; Ki Jun Jeong
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

Review 8.  Lactobacillus Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens.

Authors:  Jonathan S LeCureux; Gregg A Dean
Journal:  mSphere       Date:  2018-05-16       Impact factor: 4.389

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.